Perphenazine 2 MG Oral Tablet
INDICATIONS AND USAGE Perphenazine is indicated for use in the treatment of schizophrenia and for the control of severe nausea and vomiting in adults. Perphenazine has not been shown effective for the management of behavioral complications in patients with mental retardation.
american health packaging
ROUND GREY V 4940
V 4940 ROUND GREY
Related Pills
Perphenazine 8 MG Oral Tablet
american health packaging
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED Perphenazine tablets, USP are available as: 4 mg: gray, round, bi-convex, film-coated tablets debossed “4941” on one side and debossed “V” on the reverse side. Available as follows: Unit dose packages of 100 (10 x 10) NDC 68084-602-01 8 mg: gray, round, bi-convex, film-coated tablets debossed “4942” on one side and debossed “V” on the reverse side. Available as follows: Unit dose packages of 100 (10 x 10) NDC 68084-607-01 Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. FOR YOUR PROTECTION: Do not use if blister is torn or broken.
More pills like ROUND V 4940